These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33020180)

  • 1. Representative cancer-associated U2AF2 mutations alter RNA interactions and splicing.
    Maji D; Glasser E; Henderson S; Galardi J; Pulvino MJ; Jenkins JL; Kielkopf CL
    J Biol Chem; 2020 Dec; 295(50):17148-17157. PubMed ID: 33020180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Associated Mutations Mapped on High-Resolution Structures of the U2AF2 RNA Recognition Motifs.
    Glasser E; Agrawal AA; Jenkins JL; Kielkopf CL
    Biochemistry; 2017 Sep; 56(36):4757-4761. PubMed ID: 28850223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A splice site-sensing conformational switch in U2AF2 is modulated by U2AF1 and its recurrent myelodysplasia-associated mutation.
    Warnasooriya C; Feeney CF; Laird KM; Ermolenko DN; Kielkopf CL
    Nucleic Acids Res; 2020 Jun; 48(10):5695-5709. PubMed ID: 32343311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A UHM-ULM interface with unusual structural features contributes to U2AF2 and SF3B1 association for pre-mRNA splicing.
    Galardi JW; Bela VN; Jeffery N; He X; Glasser E; Loerch S; Jenkins JL; Pulvino MJ; Boutz PL; Kielkopf CL
    J Biol Chem; 2022 Aug; 298(8):102224. PubMed ID: 35780835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal.
    Glasser E; Maji D; Biancon G; Puthenpeedikakkal AMK; Cavender CE; Tebaldi T; Jenkins JL; Mathews DH; Halene S; Kielkopf CL
    Nucleic Acids Res; 2022 May; 50(9):5299-5312. PubMed ID: 35524551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-Atom Simulations Elucidate the Impact of U2AF2 Cancer-Associated Mutations on Pre-mRNA Recognition.
    Rozza R; Saltalamacchia A; Orrico C; Janoš P; Magistrato A
    J Chem Inf Model; 2022 Dec; 62(24):6691-6703. PubMed ID: 36040856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNRNPA1 promotes recognition of splice site decoys by U2AF2 in vivo.
    Howard JM; Lin H; Wallace AJ; Kim G; Draper JM; Haeussler M; Katzman S; Toloue M; Liu Y; Sanford JR
    Genome Res; 2018 May; 28(5):689-698. PubMed ID: 29650551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic small molecule stalls pre-mRNA splicing by promoting an early-stage U2AF2-RNA complex.
    Chatrikhi R; Feeney CF; Pulvino MJ; Alachouzos G; MacRae AJ; Falls Z; Rai S; Brennessel WW; Jenkins JL; Walter MJ; Graubert TA; Samudrala R; Jurica MS; Frontier AJ; Kielkopf CL
    Cell Chem Biol; 2021 Aug; 28(8):1145-1157.e6. PubMed ID: 33689684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro iCLIP-based modeling uncovers how the splicing factor U2AF2 relies on regulation by cofactors.
    Sutandy FXR; Ebersberger S; Huang L; Busch A; Bach M; Kang HS; Fallmann J; Maticzka D; Backofen R; Stadler PF; Zarnack K; Sattler M; Legewie S; König J
    Genome Res; 2018 May; 28(5):699-713. PubMed ID: 29643205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An autoinhibitory intramolecular interaction proof-reads RNA recognition by the essential splicing factor U2AF2.
    Kang HS; Sánchez-Rico C; Ebersberger S; Sutandy FXR; Busch A; Welte T; Stehle R; Hipp C; Schulz L; Buchbender A; Zarnack K; König J; Sattler M
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7140-7149. PubMed ID: 32188783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Architecture of SF3b and Structural Consequences of Its Cancer-Related Mutations.
    Cretu C; Schmitzová J; Ponce-Salvatierra A; Dybkov O; De Laurentiis EI; Sharma K; Will CL; Urlaub H; Lührmann R; Pena V
    Mol Cell; 2016 Oct; 64(2):307-319. PubMed ID: 27720643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of the 3' splice site RNA by the U2AF heterodimer involves a dynamic population shift.
    Voith von Voithenberg L; Sánchez-Rico C; Kang HS; Madl T; Zanier K; Barth A; Warner LR; Sattler M; Lamb DC
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7169-E7175. PubMed ID: 27799531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.
    Loerch S; Leach JR; Horner SW; Maji D; Jenkins JL; Pulvino MJ; Kielkopf CL
    J Biol Chem; 2019 Feb; 294(8):2892-2902. PubMed ID: 30567737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of the aberrant 3' splice site selection by cancer-associated mutations on the U2AF1.
    Yoshida H; Park SY; Sakashita G; Nariai Y; Kuwasako K; Muto Y; Urano T; Obayashi E
    Nat Commun; 2020 Sep; 11(1):4744. PubMed ID: 32958768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stuck on UUUU: New splicing inhibitors enhance U2AF2-RNA binding.
    Love SL; Hoskins AA
    Cell Chem Biol; 2021 Aug; 28(8):1106-1108. PubMed ID: 34416141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution conformation and thermodynamic characteristics of RNA binding by the splicing factor U2AF65.
    Jenkins JL; Shen H; Green MR; Kielkopf CL
    J Biol Chem; 2008 Nov; 283(48):33641-9. PubMed ID: 18842594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing Factor Mutations in Cancer.
    Bejar R
    Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global developmental delay, systemic dysmorphism and epilepsy in a patient with a de novo U2AF2 variant.
    Hiraide T; Tanaka T; Masunaga Y; Ohkubo Y; Nakashima M; Fukuda T; Ogata T; Saitsu H
    J Hum Genet; 2021 Dec; 66(12):1185-1187. PubMed ID: 34112922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.
    Whisenant TC; Peralta ER; Aarreberg LD; Gao NJ; Head SR; Ordoukhanian P; Williamson JR; Salomon DR
    PLoS One; 2015; 10(12):e0144409. PubMed ID: 26641092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing.
    Laliotis GI; Chavdoula E; Paraskevopoulou MD; Kaba A; La Ferlita A; Singh S; Anastas V; Nair KA; Orlacchio A; Taraslia V; Vlachos I; Capece M; Hatzigeorgiou A; Palmieri D; Tsatsanis C; Alaimo S; Sehgal L; Carbone DP; Coppola V; Tsichlis PN
    Nat Commun; 2021 Jul; 12(1):4624. PubMed ID: 34330897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.